Abstract
Objective
To identify differences in survival among women diagnosed with cancer of the anal canal from varying racial and ethnic backgrounds.
Methods
Data from the Surveillance, Epidemiology and End Results (SEER) registry between the years of 1975 and 2016 were analyzed, which included 19,048 women with cancer of the anal canal. Multivariable Cox proportional hazard regression (HRs) was performed to examine the relative risk of dying among women with anal cancer. Multivariable odds ratios (ORs) with 95% confidence intervals (CIs) were used to examine odds of highly fatal disease (death within 12 months from diagnosis).
Results
Non-Hispanic Black women (n = 1694) had greater risk of dying when compared with non-Hispanic White women (n = 15,821) with anal cancer (HR = 1.26, CI: 1.17–1.35), independent of other prognostic indicators. Stratifying by age at diagnosis, risk of death was highest for non-Hispanic Black women diagnosed younger than age 50 years compared with non-Hispanic White women of similar age (HR = 1.60, CI: 1.34–1.89), and lowest for Hispanic women (n = 1533) older than 74 years at diagnosis (HR = 0.80, CI: 0.69–0.92). Stratifying by stage at diagnosis, disparities were not observed. When comparing across years of diagnoses, non-Hispanic Black women consistently had poorer survival compared with non-Hispanic White women diagnosed in the same year intervals. Finally, non-Hispanic Black women had greater odds of highly fatal disease (OR = 1.23, CI: 1.08–1.40) compared with non-Hispanic White women.
Conclusion
Non-Hispanic Black women with anal cancer continue to experience poorer survival compared with non-Hispanic White women, whereas disparities were not identified for Hispanic women.
Similar content being viewed by others
Data Availability
All data for this study was provided to us and abstracted from Surveillance, Epidemiology, and End Results (SEER) Program, which is publicly available upon request. The dataset for this study was Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2017 Sub (1995–2015) < Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission.
References
Durot C, Dohan A, Boudiaf M, Servois V, Soyer P, Hoeffel C. Cancer of the anal canal: diagnosis, staging and follow-up with MRI. Korean J Radiol. 2017;18(6):946–56.
Surveillance, E., And end results program. Cancer Stat Facts: Anal Cancer. 2019; Available from: https://seer.cancer.gov/statfacts/html/anus.html.
Cruz A, Chen D, Hsu P, Pandit V, Omesiete P, Vij P, et al. Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS). Journal of gastrointestinal oncology. 2019;10(1):37–41.
Koskan AM, LeBlanc N, Rosa-Cunha I. Exploring the perceptions of anal cancer screening and behaviors among gay and bisexual men infected with HIV. Cancer control : journal of the Moffitt Cancer Center. 2016;23(1):52–8.
Koskan AM, Fernandez-Pineda M. Anal cancer prevention perspectives among foreign-born Latino HIV-infected gay and bisexual men. Cancer control : journal of the Moffitt Cancer Center. 2018;25(1):1073274818780368.
Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101(2):281–8.
Gupta A, et al. Racial and gender disparities in therapy and outcomes of squamous cell cancer of the anus. Journal of Clinical Oncology. 2017;35(4_suppl):691–691.
Ramey SJ, Rich BJ, Kwon D, Mellon EA, Wolfson A, Portelance L, et al. Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis. Journal of gastrointestinal oncology. 2018;9(6):1109–26.
Viens LJ, et al. Human Papillomavirus-Associated Cancers - United States, 2008-2012. MMWR. Morbidity and mortality weekly report. 2016;65(26):661–6.
Deshmukh, A.A., Suk R., Shiels M.S., Sonawane K., Nyitray A.G., Liu Y., Gaisa M.M., Palefsky J.M., Sigel K., Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015. J Natl Cancer Inst, 2019.
Hoff PM, Coudry R, Moniz CMV. Pathology of anal cancer. Surg Oncol Clin N Am. 2017;26(1):57–71.
Symer, M.M. and H.L. Yeo, Recent advances in the management of anal cancer. F1000Research, 2018. 7: p. F1000 Faculty Rev-1572.
Das P, Crane CH, Eng C, Ajani JA. Prognostic factors for squamous cell cancer of the anal canal. Gastrointestinal cancer research : GCR. 2008;2(1):10–4.
Wan JF, Yang LF, Shen YZ, Jia HX, Zhu J, Li GC, et al. Sex, race, and age disparities in the improvement of survival for gastrointestinal cancer over time. Sci Rep. 2016;6:29655.
Feagin J, Bennefield Z. Systemic racism and U.S. health care. Soc Sci Med. 2014;103:7–14.
Kim HJ, Huh JW, Kim CH, Lim SW, Nam TK, Kim HR, et al. Long-term outcomes of chemoradiation for anal cancer patients. Yonsei Med J. 2013;54(1):108–15.
Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D. Anal cancer treatment: current status and future perspectives. World J Gastroenterol. 2015;21(8):2294–302.
Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(2):198–206.
Stier EA, Chiao EY. Anal Cancer and anal cancer precursors in women with a history of HPV-related dysplasia and cancer. Seminars in colon & rectal surgery. 2017;28(2):97–101.
Mai S, Welzel G, Ottstadt M, Lohr F, Severa S, Prigge ES, et al. Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer. Int J Radiat Oncol Biol Phys. 2015;93(4):819–27.
Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(29):784–92.
Daniel-Ulloa J, Gilbert PA, Parker EA. Human papillomavirus vaccination in the United States: uneven uptake by gender, race/ethnicity, and sexual orientation. Am J Public Health. 2016;106(4):746–7.
Moskowitz DA, Rahman M, Li DH. Exploring anal self-examination as a screening tool for women at risk for anal cancer: awareness, interest, and barriers to behavioral uptake. Cancer Causes Control. 2019;30(6):559–68.
Author information
Authors and Affiliations
Contributions
This article was written by AES, NFS, and KBM.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 25 kb)
Rights and permissions
About this article
Cite this article
Stenzel, A.E., Schlecht, N.F. & Moysich, K.B. Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. J Gastrointest Canc 52, 854–862 (2021). https://doi.org/10.1007/s12029-020-00472-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-020-00472-2